Literature DB >> 1575286

Grading of hepatic schistosomiasis by the use of ultrasonography.

M F Abdel-Wahab1, G Esmat, A Farrag, Y A el-Boraey, G T Strickland.   

Abstract

Forty-three subjects with pure hepatic schistosomiasis having ultrasonographic assessment of periportal fibrosis were grouped according to the thickness of their portal tracts: grade I = 3-5 mm, grade II = greater than 5-7 mm, and grade III = greater than 7 mm. A history of hematemesis, blood transfusion, sclerotherapy, and lower limb edema correlated with the ultrasonographic grade of periportal fibrosis. With increasing grade, the average liver size was smaller and the average spleen size was larger, as determined by physical examination and by ultrasonography. Abnormalities in serum enzyme levels were more frequent in those with thicker portal tracts. Greater diameters of the portal and splenic veins and ultrasonographically detectable collateral blood vessels were associated with increasing thickness of portal tracts. The grade of endoscopically determined esophageal varices was highly correlated with the grade of periportal fibrosis. We concluded that this method of grading accurately reflects the hemodynamic changes and provides a good estimate of the clinical status of patients who have periportal fibrosis due to schistosomiasis mansoni. Where available, it should replace clinical grading based upon the liver and spleen size as detected by physical examination.

Entities:  

Mesh:

Year:  1992        PMID: 1575286     DOI: 10.4269/ajtmh.1992.46.403

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

Review 1.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

Review 2.  Gastrointestinal manifestations of schistosomiasis.

Authors:  G T Strickland
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

3.  Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.

Authors:  Ghada Boghdadi; Dalia Abdel Khalik; Sami Abdel Wahab; Adel Farghaly
Journal:  Parasitol Res       Date:  2012-09-20       Impact factor: 2.289

4.  Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).

Authors:  Gamal Shiha; Shiv Kumar Sarin; Alaa Eldin Ibrahim; Masao Omata; Ashish Kumar; Laurentius A Lesmana; Nancy Leung; Nurdan Tozun; Saeed Hamid; Wasim Jafri; Hitoshi Maruyama; Pierre Bedossa; Massimo Pinzani; Yogesh Chawla; Gamal Esmat; Wahed Doss; Taher Elzanaty; Puja Sakhuja; Ahmed Medhat Nasr; Ashraf Omar; Chun-Tao Wai; Ahmed Abdallah; Mohsen Salama; Abdelkhalek Hamed; Ayman Yousry; Imam Waked; Medhat Elsahar; Amr Fateen; Sherif Mogawer; Hassan Hamdy; Reda Elwakil
Journal:  Hepatol Int       Date:  2008-12-04       Impact factor: 6.047

5.  Potential role of the chemokine macrophage inflammatory protein 1alpha in human and experimental schistosomiasis.

Authors:  Adriano L S Souza; Ester Roffê; Vanessa Pinho; Danielle G Souza; Adriana F Silva; Remo C Russo; Rodrigo Guabiraba; Cíntia A J Pereira; Flávia M Carvalho; Michele M Barsante; Rodrigo Correa-Oliveira; Lúcia A O Fraga; Deborah Negrão-Correa; Mauro M Teixeira
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.

Authors:  L F Alves Oliveira; E C Moreno; G Gazzinelli; O A Martins-Filho; A M S Silveira; A Gazzinelli; L C C Malaquias; P LoVerde; P Martins Leite; R Correa-Oliveira
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Cytokine secretion profile associated with periportal fibrosis in S. mansoni-infected Egyptian patients.

Authors:  Roba M Talaat; Azza I El-Bassiouny; Ahmed M Osman; Magdy Yossif; Ragia Charmy; Maged M Al-Sherbiny
Journal:  Parasitol Res       Date:  2007-02-25       Impact factor: 2.289

8.  HTLV-1 modifies the clinical and immunological response to schistosomiasis.

Authors:  A F Porto; S B Santos; L Alcantara; J B Guerreiro; J Passos; T Gonzalez; F Neva; D Gonzalez; J L Ho; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

9.  Periportal fibrosis and other liver ultrasonography findings in vinyl chloride workers.

Authors:  M Maroni; F Mocci; S Visentin; G Preti; A C Fanetti
Journal:  Occup Environ Med       Date:  2003-01       Impact factor: 4.402

10.  Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.

Authors:  P Martins-Leite; G Gazzinelli; L F Alves-Oliveira; A Gazzinelli; L C C Malaquias; R Correa-Oliveira; A Teixeira-Carvalho; A M S Silveira
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.